BMO Capital Markets Has Lowered Expectations for Exelon (NASDAQ:EXC) Stock Price

Key Points

• BMO Capital Markets lowered Exelon’s price target from $47 to $45 while maintaining a “market perform” rating, implying roughly 1.45% upside from the prior close.
• Analyst sentiment is broadly cautious: Exelon has a consensus “Hold” rating and an average price target of $48.58, with several firms recently reducing their targets.
• Exelon’s latest quarterly results slightly missed EPS expectations but exceeded revenue forecasts, while institutional investors own approximately 80.92% of the company’s shares.

Exelon (NASDAQ:EXC - Get Free Report) had its price objective decreased by investment analysts at BMO Capital Markets from $47.00 to $45.00 in a note issued to investors on Thursday. The brokerage presently has a "market perform" rating on the stock. BMO Capital Markets's price target indicates a potential upside of 1.45% from the stock's previous close.

A number of other brokerages also recently weighed in on EXC. Argus lowered their target price on shares of Exelon from $52.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, September 22nd. Barclays lowered their price objective on shares of Exelon from $49.00 to $44.00 and set an "equal weight" rating for the company in a research note on Monday. Morgan Stanley cut their target price on shares of Exelon from $50.00 to $49.00 and set an "equal weight" rating on the stock in a research note on Wednesday. Weiss Ratings reiterated a "buy (b-)" rating on shares of Exelon in a report on Tuesday, October 6th. Finally, HSBC initiated coverage on shares of Exelon in a research report on Thursday. They set a "hold" rating and a $44.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $48.58.

Exelon Price Performance

Exelon stock traded down $0.49 during midday trading on Thursday, reaching $44.35. The company's stock had a trading volume of 2,518,598 shares, compared to its average volume of 8,282,695. The stock has a market cap of $45.79 billion, a PE ratio of 16.24, a price-to-earnings-growth ratio of 2.35 and a beta of 0.30. The company has a current ratio of 1.09, a quick ratio of 0.99 and a debt-to-equity ratio of 1.71. Exelon has a 52 week low of $39.73 and a 52 week high of $50.65. The business has a 50-day moving average price of $42.86 and a 200-day moving average price of $45.04.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.01). Exelon had a net margin of 10.99% and a return on equity of 9.81%. The company had revenue of $5.97 billion during the quarter, compared to the consensus estimate of $5.44 billion. During the same period in the previous year, the company earned $0.39 EPS. Exelon's revenue for the quarter was up 10.0% on a year-over-year basis. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. On average, sell-side analysts predict that Exelon will post 2.86 EPS for the current year.

Hedge Funds Weigh In On Exelon

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of Exelon in the 2nd quarter worth approximately $5,583,709,000. Lazard Asset Management LLC increased its position in Exelon by 6.4% in the first quarter. Lazard Asset Management LLC now owns 24,620,304 shares of the company's stock worth $1,206,887,000 after buying an additional 1,490,251 shares during the last quarter. GQG Partners LLC purchased a new stake in Exelon in the second quarter worth $922,917,000. Legal & General Group Plc bought a new stake in shares of Exelon in the second quarter valued at $602,760,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Exelon in the second quarter valued at $580,842,000. 80.92% of the stock is owned by hedge funds and other institutional investors.

Exelon Company Profile

Exelon Corporation NASDAQ: EXC is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.

Exelon's utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.